Month: May 2025

Hi-View Resources Acquires Additional Claims Contagious to Lawyers East Block in the Toodoggone District

Written by Customer Service on May 13, 2025. Posted in Public Companies.

VANCOUVER, British Columbia, May 13, 2025 (GLOBE NEWSWIRE) — HI-VIEW RESOURCES INC. (‘HI-VIEW’ OR THE ‘COMPANY’) (CSE: HVW; OTCQB: HVWRF; FSE: B63) announces that it has entered into an agreement with three arms-length vendors to acquire a 100% interest 613.24 hectares of contiguous claim in close proximity to Amarc Resources Ltd.’s (“Amarc”) and Freeport-McMoRan Inc.’s (“Freeport”) recently announced drilling discovery at the AuRORA porphyry target. (See Amarc News Release dated January 20th, 2025). The new claims are located contiguous to Hi-View’s Lawyers East claim block that is contiguous to the western flank of Amarc’s JOY Property. See project page for more information: Toodoggone Mining District – Hi-View Resources Hi-View Resources CEO Robert Nick Horsley states, “In 2025, the Toodoggone Region has solidified...

Syensqo announces revised segment reporting

Written by Customer Service on May 13, 2025. Posted in Public Companies.

Syensqo announces revised segment reporting Consumer & Resources segment renamed Performance & Care, focused on Novecare & Technology Solutions New “Other Solutions” segment comprised of Aroma Performance and Oil & Gas Brussels, Belgium – May 13, 2025 – 8:30 CEST Syensqo SA (“Syensqo” or the “Company”) today announced that it has changed its segment reporting structure to align with its previously announced intention to divest its Oil & Gas and Aroma Performance business units. Effective from the first quarter of 2025, the Company will disclose net sales, underlying EBITDA, working capital and capital expenditure for its four reportable segments; Materials, Performance & Care, Other Solutions and Corporate & Business Services:Materials will continue to consist of the Specialty Polymers and Composite...

Mobilize and Autostrade per l’Italia complete their strategic alliance to power sustainable mobility in Italy

Written by Customer Service on May 13, 2025. Posted in Public Companies.

PRESS RELEASEParis, France – 13 May 2025 MOBILIZE AND AUTOSTRADE PER L’ITALIA COMPLETE THEIR STRATEGIC ALLIANCE TO POWER SUSTAINABLE MOBILITY IN ITALYFollowing the signing of a framework agreement announced on 14 January 2025, Renault Group, through its Mobilize brand, and Autostrade per l’Italia (ASPI), via its subsidiary Free To X, have officially confirmed their strategic alliance after receiving the necessary regulatory approvals. As part of the agreement, Mobilize has completed its acquisition of a significant stake in Free To X. The partners aim to develop fast-charging infrastructure in Italy. Mobilize is in charge of accelerating the deployment of charging infrastructure outside ASPI’s motorway network, supported by ASPI, which retains control of the charging infrastructure located along its motorway network.Through the...

RIBER secures a major order for an MBE 412 cluster system in Australia

Written by Customer Service on May 13, 2025. Posted in Public Companies.

RIBER secures a major order for an MBE 412 cluster system in Australia Bezons (France), May 13, 2025 – 8:00am (CET) – RIBER, the global leader for Molecular Beam Epitaxy (MBE) equipment for the semiconductor industry, announces the sale of a research MBE 412 cluster platform with an automatic wafer transfer system to a leading Australian research laboratory.The Western Australia Node of the Australian National Fabrication Facility (ANFF WA Node), based at the University of Western Australia, is the only research center in the country with expertise and device fabrication capabilities for infrared (IR) sensors, including high density imaging focal plane arrays. To advance its research in IR technologies and to support the development of sovereign IR sensor capabilities in Australia, the ANFF WA Node has placed an order for a new RIBER...

First patients dosed in final cohort of Phase 1b clinical trial of HER-096 for Parkinson’s disease

Written by Customer Service on May 13, 2025. Posted in Public Companies.

Herantis Pharma Plc – Press release First patients dosed in final cohort of Phase 1b clinical trial of HER-096 for Parkinson’s diseaseHER-096 is a first-in-class agent in development for the treatment of Parkinson’s disease with disease modifying potential and convenient subcutaneous administration Successful completion of the first patient cohort in Part 2 of the trial and approval to proceed from the Data and Safety Monitoring Board Primary objective is to assess the safety, tolerability and pharmacokinetics of repeated subcutaneous doses of HER-096; the trial will also evaluate selected biomarkers, discover and identify novel treatment response biomarkers and monitor symptoms associated with Parkinson’s disease Topline data from Phase 1b trial is expected in September 2025 Trial funded by the Michael J. Fox Foundation for Parkinson’s...

Quadient and Nuvei Sign New Partnership to Enhance Cloud Payment Capabilities for Businesses Globally

Written by Customer Service on May 13, 2025. Posted in Public Companies.

The partnership supports seamless, secure payments through Quadient’s AR and AP solutions for businesses across North America, the UK and EuropeQuadient (Euronext Paris: QDT), a global automation platform powering secure and sustainable business connections, and Nuvei, a leading global payments company, today announced a strategic technology partnership to enhance cloud payment capabilities for businesses globally. Through this partnership, Nuvei’s advanced payment processing technology is now integrated into Quadient’s cloud-based Accounts Receivable (AR) and Accounts Payable (AP) automation solutions, providing businesses of all sizes across North America, the UK, and Europe with a unified platform to manage B2B payments more efficiently, securely, and at scale. With the integration of advanced global payments capabilities, Quadient...

Nilfisk reports Q1 2025 results: Financial results in line with expectations – 2025 guidance maintained

Written by Customer Service on May 13, 2025. Posted in Earnings Releases And Operating Results.

Nilfisk CEO, Jon Sintorn, comments on Q1 results: “The first quarter saw high activity and strong focus on execution. Geopolitical uncertainties and recent tariff announcements have influenced overall market sentiment, as well as company operations. However, the financial development was in line with expectations, and initiatives under our strategic roadmap for 2025 are being implemented, including an overhead cost reduction program starting in Q2.” Specifically on the tariff situation, Jon Sintorn comments: “Tariffs have complicated operations in Q1 and planning for Q2. However, our flexible and robust supply chain, with production facilities in all three regions, allows us to offset the majority of tariff exposure. The remaining impact will be offset through price adjustments. Consequently, our financial guidance for 2025 is maintained.” Financial...

Galapagos Announces Strategic Update on Proposed Separation, Executive Leadership Transition and Board Changes

Written by Customer Service on May 13, 2025. Posted in Public Companies.

Galapagos to re-evaluate the implementation of the previously announced separation following regulatory and market developments Galapagos to explore all strategic alternatives for its existing businesses, including cell therapy, with a focus on maximizing resources available for transformative business development transactions Mr. Henry Gosebruch appointed by the Galapagos Board of Directors as CEO of Galapagos, effective immediately, succeeding Dr. Paul Stoffels who announced his retirement in April 2025 Mr. Jérôme Contamine, formerly Lead Non-Executive Director, has been appointed Chair of the Board of Directors of Galapagos, replacing Dr. Paul Stoffels Mechelen, Belgium; May 13, 2025, 07:30 CET; regulated information – inside information – Galapagos NV (Euronext & NASDAQ: GLPG), a global biotechnology company dedicated to transforming...

Vivoryon Therapeutics N.V. to Hold its 2025 Annual General Meeting on June 24, 2025

Written by Customer Service on May 13, 2025. Posted in Public Companies.

Vivoryon Therapeutics N.V. to Hold its 2025 Annual General Meetingon June 24, 2025 Halle (Saale) / Munich, Germany, May 13, 2025 – Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; NL00150002Q7) (Vivoryon), a clinical stage company focused on the discovery and development of small molecule medicines to modulate the activity and stability of pathologically altered proteins, today announced that its 2025 Annual General Meeting will be held on Tuesday, June 24, 2025 at 01:00 p.m. (CEST) at the Amsterdam offices of NautaDutilh N.V. The full agenda and all relevant documents are available on the Company’s website: https://www.vivoryon.com/2025-annual-general-meeting/. ### About Vivoryon Therapeutics N.V.Vivoryon is a clinical stage biotechnology company focused on developing innovative small molecule-based medicines. Driven...

Ten-year APHINITY data show Roche’s Perjeta-based regimen reduced the risk of death by 17% in people with HER2-positive early-stage breast cancer

Written by Customer Service on May 13, 2025. Posted in Public Companies.

Long term follow-up in this curative setting demonstrated clinically meaningful survival benefit when adding adjuvant Perjeta® (pertuzumab) to Herceptin® (trastuzumab) and chemotherapy1 21% reduction in the risk of death was seen in the pre-specified subgroup of people with lymph node-positive disease1 Data to be presented as a late-breaking abstract at the 2025 European Society for Medical Oncology (ESMO) Breast Cancer CongressBasel, 13 May 2025 – Roche (SIX: RO, ROG; OTCQX: RHHBY), the Breast International Group (BIG), Institut Jules Bordet Clinical Trials Support Unit and Frontier Science Foundation, announced today statistically significant final overall survival (OS) results from the phase III APHINITY study in people with human epidermal growth factor receptor 2 (HER2)-positive early-stage breast cancer.1 After ten years,...

Month: May 2025

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals